Jasper Therapeutics (JSPR) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.42
-0.33
-0.24
-0.15

Details

Expected EPS
-0.15
Actual EPS
-0.16
Surprise EPS
-0.01
Surprise Percent
+6.67%

Description

Jasper Therapeutics (JSPR) has reported earnings of -0.16 per share for Q3 2023.

0 Comments

Share your thoughts